دورية أكاديمية

Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan

التفاصيل البيبلوغرافية
العنوان: Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
المؤلفون: Liu, Chen-HuaAff1, Aff2, Aff3, Chen, Po-Yueh, Chen, Jyh-Jou, Lo, Ching-Chu, Su, Wei-Wen, Tseng, Kuo-ChihAff8, Aff9, Liu, Chun-JenAff1, Aff2, Huang, Chia-Sheng, Huang, Ke-Jhang, Yang, Sheng-ShunAff12, Aff13, Aff14, Peng, Cheng-YuanAff15, Aff16, Tsai, Ming-Chang, Kao, Wei-YuAff18, Aff19, Aff20, Chang, Chi-Yang, Shih, Yu-Lueng, Fang, Yu-Jen, Chen, Chi-Yi, Lee, Pei-Lun, Huang, Jow-Jyh, Su, Pei-Yuan, Tseng, Chi-WeiAff8, Aff9, Hung, Chien-ChingAff1, Aff23, Chang, Chung-Hsin, Huang, Yi-Jie, Lai, Hsueh-ChouAff15, Aff16, Chang, Chun-ChaoAff18, Aff19, Aff20, Lee, Fu-Jen, Hsieh, Tsai‐Yuan, Kao, Jia-HorngAff1, Aff2, Aff24
المصدر: Hepatology International. 15(2):338-349
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:19360533
19360541
DOI:10.1007/s12072-021-10158-x